NCT00667225
Efficacy of Cantharidin in Molluscum Contagiosum
Sponsored by University of North Carolina, Chapel Hill
The University of North Carolina Department of Dermatology is conducting a clinical trial to evaluate a drug called cantharidin in the treatment of molluscum contagiosum. Molluscum is a common dermatologic disorder caused by a poxvirus. Molluscum typically presents with many flesh-colored bumps on the skin. It goes away on its own, though can last several months to several years. Cantharidin is a topical medicine which is applied at the clinic visit. It is well tolerated by the majority of children.
Inclusion Criteria: * Anyone aged 5-10 years with the clinical diagnosis of molluscum contagiosum. Exclusion Criteria: * Anyone with immunosuppression including HIV or previous organ transplantation. * Anyone taking immunosuppressive medications. * Anyone who has previously received treatment with cantharidin. * Any female who has had her first menstrual period.
University of North Carolina
Chapel Hill, North Carolina, United States
Identity-resolution confidence concerns registry/entity resolution and does not determine clinical eligibility.
Interested in this trial?
Express your interest and we'll connect you with the trial team.
Your selected profile and contact information may be shared with an authorised trial site, sponsor, or Clintriva coordination team for trial contact and pre-screening. Expressing interest does not mean you are eligible or enrolled.
Conditions